In glioma cell cultures, silencing of uPAR and cathepsin B downregulates the expression of CD133, Nestin, Sox2 and Bmi1 and reduces the number of glioma-initiating cells (Gopinath et al., 2013). Here, NES is linked to central nervous system cancer.